HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform.
HeartBeat.bio has raised $4.8M in total funding. The most recent round was Seed. The last funding was announced in November 2023.
HeartBeat.bio's investors include aws Grundungsfonds, Tensor Ventures, red-stars.com, i&i Biotech Fund, INVEST AG.
HeartBeat.bio is headquartered in Vienna, Austria.
HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform.
HeartBeat.bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HeartBeat.bio — Funding & Investors." VCBacked, November 2, 2023, https://www.vcbacked.co/company/heartbeatbio. Accessed July 31, 2026.
VCBacked. (2023). HeartBeat.bio — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/heartbeatbio
{{cite web |title=HeartBeat.bio — Funding & Investors |url=https://www.vcbacked.co/company/heartbeatbio |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated